• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Medipharm Labs Corp (TSX: LABS )

    0.0750 UNCHANGED
    Streaming Delayed Price Updated: 10:19 AM EST, Nov 13, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Headline News about Medipharm Labs Corp

    MediPharm Q2 Loss Narrows, Adjusted EBITDA Climbs As Gross Profit Improves Nearly 300% YoY
    Cannabinoids-focused pharmaceutical company MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) announced on Wednesday financial results for the second quarter ended June 30, 2024, revealing an... 
    Via Benzinga
    Topics Cannabis
    Exposures Cannabis
    This Cannabis Co With Significant Growth Potential And Other Hot Weed Stocks Soon To Report Earnings, What Investors Need To Know Now
    Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF), a cannabis operator with vertical operations in Arizona and Ohio, said it will release its financial results for the second quarter ended June 30, 2024,... 
    Via Benzinga
    Topics Cannabis
    Exposures Cannabis
    Executive Changes In Cannabis Industry You Should Know About, New Appointments & More
    Shareholders of four cannabis companies held their respective annual meetings, electing nominees as board directors.Sandy Li, who has been serving at cannabis edibles producer Wana Brands since 2022 as... 
    Via Benzinga
    Topics Cannabis
    Exposures Cannabis
    Cannabinoids-Focused MediPharm Boasts This Advanced Medical Cannabis Delivery Method
    Cannabinoids-based pharmaceutical company MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) announced on Thursday that it has entered into a licensing agreement with Remidose Aerosols Inc. to... 
    Via Benzinga
    Topics Cannabis
    Exposures Cannabis
    Cannabinoids-Focused Pharma Company, MediPharm, Sees Higher Q1 Revenue, CFO Touts 'Strong Financial Position'
    Via Benzinga
    This Cannabinoids-Focused Pharma Co. Sees 50% YoY Surge In Revenue In 2023, Trims Losses
    Cannabinoids-focused pharmaceutical company MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) announced on Wednesday its financial results for the full year and three months ended Dec. 31,... 
    Via Benzinga
    Canadian CBD-Focused Pharma Co. Gets Green Light To Produce Medical Marijuana In Brazil
    Canada's MediPharm Labs has received a GMP certification from the Brazilian governing body, ANVISA. The approval allows for the production of active pharmaceutical ingredients (APIs) and end products... 
    Via Benzinga
    Topics Cannabis
    Exposures Cannabis Product Safety
    Key Leadership Changes In Cannabis You Should Know About As We Head Into 2024
    This month, the Indigenous Cannabis Industry Association held its first Indigenous Cannabis Regulators roundtable, bringing together Indigenous Cannabis Regulators from Tribal Nations and... 
    Via Benzinga
    Topics Cannabis
    Exposures Cannabis
    MediPharm Labs Still Hits C$8.5M Despite Sequential Drop, More On That In Q3 2023 Financial Report
    MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) reported its financial results for the three months ended September 30, 2023, with a revenue of C$8.5 million. This reflects a decrease of... 
    Via Benzinga
    MediPharm Settles Commercial Agreement Dispute With Tilray's Hexo For $9M
    MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) entered into a settlement agreement on September 29, 2023 to resolve a claim in connection with a commercial agreement dis 
    Via Benzinga
    MediPharm Labs Breaks Free From Royalty Agreement, What It Means & What's Next
    MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) has executed a supplementary agreement to its asset purchase agreement with 1193269 B.C. 
    Via Benzinga
    MediPharm Labs Sees 16.5% QoQ Increase In International Medical Cannabis Sales, Announces New CEO
    CBD-focused pharmaceutical company MediPharm Labs Corp. (TSX:LABS... 
    Via Benzinga
    Topics Cannabis
    Exposures Cannabis
    MediPharm Labs Taps Bryan Howcroft as Chief Executive Officer And Director
    MediPharm Labs Corp. (TSX:LABS) (OTCQX: 
    Via Benzinga
    MediPharm Labs To Provide Materials For Clinical Trial On CBD For Insomnia
    MediPharm Labs Corp. (TSX:LABS) (OTCQX: 
    Via Benzinga
    MediPharm Labs Reports 24% QoQ Pop In International Sales, Q2 2021 Revenue Drops 63.6% YoY
    MediPharm Labs Corp. (TSX:LABS) (OTCQX: 
    Via Benzinga
    MediPharm Labs Receives Canadian GMP Pharmaceutical Drug Establishment License
    Pharmaceutical company MediPharm Labs Corp. (TSX:LABS) (OTCQX... 
    Via Benzinga
    MediPharm Labs Extends Collaboration With German Medical Cannabis Distributor ADREXpharma
    MediPharm Labs Corp. (TSX:LABS) (OTCQX: 
    Via Benzinga
    Topics Cannabis
    Exposures Cannabis
    MediPharm Posts Q1 2021 Results: What Cannabis Stock Investors Need To Know
    MediPharm Labs Corp. (TSX:LABS) (OTCQX: 
    Via Benzinga
    Topics Cannabis
    Exposures Cannabis
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.